GLIOMAS. VOLUME 134

GLIOMAS. VOLUME 134

Editorial:
ACADEMIC PRESS
Año de edición:
Materia
Neurología
ISBN:
978-0-12-802997-8
Páginas:
464
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 10 días

Descuento:

-5%

Antes:

208,00 €

Despues:

197,60 €

• Section 1: Diagnosis and treatment
Chapter 1: Epidemiology
Chapter 2: Presenting signs and symptoms in brain tumors
Chapter 3: Neuroimaging
Chapter 4: Surgical approaches for the gliomas
Chapter 5: Histologic classification of gliomas
Chapter 6: Molecular classification of gliomas
Chapter 7: Next-generation molecular diagnostics
Chapter 8: Principles of radiation therapy
Chapter 9: Principles of pharmacotherapy
Chapter 10: Principles of immunotherapy
Chapter 11: Experimental therapies: gene therapies and oncolytic viruses
• Section 2: Complications and symptomatic management
Chapter 12: Complications of glioma surgery
Chapter 13: Complications from radiotherapy
Chapter 14: Complications from pharmacotherapy
Chapter 15: Vascular complications in glioma patients
Chapter 16: Epilepsy and brain tumors
Chapter 17: Rehabilitation of patients with glioma
Chapter 18: Psycho-oncology
Chapter 19: Palliative care at the end-of-life in glioma patients
• Section 3: Disease-specific chapters
Chapter 20: Pilocytic astrocytomas
Chapter 21: Astrocytic gliomas WHO grades II and III
Chapter 22: Low-grade and anaplastic oligodendroglioma
Chapter 23: Glioblastoma
Chapter 24: Rare glial tumors
Chapter 25: Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options
• Index

Features:
• Synthesizes widely dispersed information on the management of gliomas into one comprehensive resource
• Chapters written by international authors who are preeminent researchers in the field
• Fully explores the therapeutic options for patient care, from chemotherapy to radiotherapy to personalized approaches

Authors
• Mitchel S. Berger, Kathleen M. Plant Distinguished Professor and Chairman, Department of Neurological Surgery; Director, Neurological Surgery Research Centers and Brain Tumor Research Center; Director, Brain Tumor Surgery Program, University of California, San Francisco, San Francisco.
• Michael Weller, Department of Neurology, University Hospital Zurich, Zurich, Switzerland